Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

"An Accord for a Healthier World" focuses on five areas: infectious diseases, cancer, inflammation, rare diseases and women's health -- whe...

The Russian invasion has left drugmakers scrambling to find ways for patients enrolled in clinical trials in Ukraine to receive their medic...

These medicines, valued at more than USD 70 million, will be made available immediately, said company's Chairman.

As per the report, Pfizer offered $90 per share in cash, a 39 percent premium to Hospira's closing stock price on Wednesday

"Pfizer has been forced to issue a lockout notice at its Thane manufacturing plant to ensure the safety of our colleagues"

A group of US pharmacies filed lawsuit against Ranbaxy, Pfizer & accused the two drug firms of delaying the launch of Lipitor in the US

US pharmaceutical giant Pfizer said Wednesday it has bought 40 percent of Brazilian drug company Teuto for 238 million dollars as part of i...

PFIZER has entered into a series of agreements with Aurobindo Pharma to market medicines that are no longer patent protected and don’t have...

Pfizer Inc has agreed to license an array of generic pills and injectable medicines from India's Aurobindo Pharma Ltd as the world's larges...

Insulin brands, steroids and painkillers may become more expensive once NPPA revises prices of more than 170 medicines, in some cases by as...